Healthcare & Life Sciences

Healthcare in the United States is consolidating in slow motion, with the mid-market squeezed between national platforms with capital advantages and local incumbents with relationship advantages. Halverson Reed advises providers, healthcare services businesses, and the smaller life-sciences companies whose decisions about scale, geography, and capability are no longer optional.

Our engagements typically address one of three questions. Where should we compete? How do we operate well enough to remain independent — or attractive enough to be acquired on our own terms? And how do we build the capabilities, particularly in technology and data, that the next generation of payor and patient expectations will demand?

Margaret Reed expanded the firm into healthcare in the early 1980s, and the practice has remained a meaningful part of the firm ever since. Our work is conducted with the discretion the sector requires — and with a clear-eyed view of what mid-market healthcare organizations can realistically execute, given the constraints they face.